81631-4
Methotrexate polyglutamates [Interpretation] in Red Blood Cells Narrative
Active
Term Description
The overall interpretation of methotrexate polyglutamates (MTX-PGs) measurement results in red blood cells. Results are used to guide treatment planning and evaluation for various diseases, including rheumatoid arthritis.
Part Description
LP188434-7 Methotrexate polyglutamates
Methotrexate (MTX) is a drug that is used to treat certain types of cancer as well as auto-immune diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus and psoriasis. After uptake of MTX into cells, MTX is activated by the addition of glutamate residues and forms methotrexate polyglutamates (MTX-PGs), which are named based on the number of added glutamate residues (e.g. methotrexate triglutamate, MTX-PG3). The half-life of MTX in plasma is only several hours where as MTX PGs can persist in cells for weeks or months. PMID: 15677700 While high-dose MTX in the treatment of malignancy is due to the direct effect on tetrahydrofolate reductase and DNA synthesis, the long-term immune modulation of low-dose MTX therapy appears to be related to multiple metabolic effects of the MTX PGs. PMID: 20665136 Red blood cell MTX PG levels may be a marker for therapeutic response in patients treated with low-dose MTX, and low red blood cell MTX PG has been associated with poor clinical status in patients with RA. PMID: 15677700
Source: Regenstrief LOINC
, PMID: 15677700
Fully-Specified Name
- Component
- Methotrexate polyglutamates
- Property
- Imp
- Time
- Pt
- System
- RBC
- Scale
- Nar
- Method
Additional Names
- Long Common Name
- Methotrexate polyglutamates [Interpretation] in Red Blood Cells Narrative
- Short Name
- MTX-PGs RBC-Imp
- Display Name
- Methotrexate polyglutamates Nar (RBC) [Interp]
- Consumer Name Alpha Get Info
- Interpretation of Methotrexate polyglutamates test result, Red blood cells
Basic Attributes
- Class
- DRUG/TOX
- Type
- Laboratory
- First Released
- Version 2.56
- Last Updated
- Version 2.56 (ADD)
- Order vs. Observation
- Observation
Member of these Panels
LOINC | Long Common Name |
---|---|
81630-6 | Methotrexate polyglutamates 1-5 and total panel - Red Blood Cells |
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
el-GR | Greek (Greece) | Πολυγλουταμινική μεθοτρεξάτη: Synonyms: Imp Μεθοτρεξάτη Πολυγλουταμινική μεθοτρεξάτη |
es-ES | Spanish (Spain) | Metotrexato poliglutamato: |
es-MX | Spanish (Mexico) | Poliglutamatos de metotrexato: |
fr-FR | French (France) | Méthotrexate polyglutamates: |
it-IT | Italian (Italy) | Metotrexato poliglutammati: Synonyms: Globuli rossi Impressione/interpretazione di studio Livelli farmacologici e tossicologia Punto nel tempo (episodio) |
nl-NL | Dutch (Netherlands) | methotrexaat-polyglutamaat: Synonyms: rode bloedcellen |
tr-TR | Turkish (Turkey) | Metotreksat poliglutamat: Synonyms: RBC |
zh-CN | Chinese (China) | 氨甲蝶呤多聚谷氨酸: Synonyms: C20H22N8O5; |
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=81631-4
LOINC Copyright
Copyright © 2025 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://